Top Story

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014

BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses an important challenge with several ramifications, according to Francesco Rubino, MD, professor and chair of bariatric and metabolic surgery at King's College London in London.

While evidence has emerged that gastrointestinal surgery can improve diabetes, reduce cardiometabolic risk and prolong survival, indications for bariatric surgery are primarily based on weight, which poses a barrier to access for many patients, he said.

figure Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the Cardiometabolic Health…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study findings published in…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke, according to research…
CME
figure

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
figure

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
figure

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »

Filter By:

In the Journals

CTA provided accurate assessment of arterial plaque in patients with diabetes

Cardiology Today, June 2014
Quantitative plaque analysis with coronary CTA was an accurate assessment of calcified and noncalcified arterial plaque in patients with diabetes…
Meeting News Coverage

Philip Schauer, MD, offers investigator insight into 3-year STAMPEDE results

April 6, 2014
WASHINGTON — In this video, Philip Schauer, MD, director of the Cleveland Clinic Bariatric and Metabolic Institute, outlines the 3-year…
In the Journals

Lifestyle changes reduced mortality, diabetes rate in adults with IGT

April 3, 2014
The potential for weight loss and exercise to prevent deaths from cardiovascular disease and all-causes in adults with impaired glucose tolerance is…
Meeting News Coverage Video

Darren K. McGuire, MD, MHSc, on the 3-year STAMPEDE trial results

April 1, 2014
WASHINGTON — In this video, Darren K. McGuire, MD, MHSc, professor of internal medicine and Dallas Heart Ball Chair for research on heart…
In the Journals

Intensive BP, lipid regimens improved CVD outcomes in diabetes

March 31, 2014
Compared with combined standard treatment options, intensive blood pressure or intensive glycemia treatment alone were shown to improve major…
Meeting News Coverage Perspective

Bariatric surgery provided long-term diabetes control out to 3 years

March 31, 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News Coverage Perspective Publication Exclusive

Bariatric surgery provided long-term diabetes control out to 3 years

Cardiology Today, May 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

March 30, 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

Cardiology Today, May 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
In the Journals

Blood glucose measures offered little benefit for CVD risk prediction

March 25, 2014
Assessment of HbA1c values in the context of CVD risk assessment may provide little incremental benefit for the prediction of CVD risk in people…
More Headlines »